Literature DB >> 11251249

Block copolymer micelles for drug delivery: design, characterization and biological significance.

K Kataoka1, A Harada, Y Nagasaki.   

Abstract

Recently, colloidal carrier systems have been receiving much attention in the field of drug targeting because of their high loading capacity for drugs as well as their unique disposition characteristics in the body. This paper highlights the utility of polymeric micelles formed through the multimolecular assembly of block copolymers as novel core-shell typed colloidal carriers for drug and gene targeting. The process of micellization in aqueous milieu is described in detail based on differences in the driving force of core segregation, including hydrophobic interaction, electrostatic interaction, metal complexation, and hydrogen bonding of constituent block copolymers. The segregated core embedded in the hydrophilic palisade is shown to function as a reservoir for genes, enzymes, and a variety of drugs with diverse characteristics. Functionalization of the outer surface of the polymeric micelle to modify its physicochemical and biological properties is reviewed from the standpoint of designing micellar carrier systems for receptor-mediated drug delivery. Further, the distribution of polymeric micelles is described to demonstrate their long-circulating characteristics and significant tumor accumulation, emphasizing their promising utility in tumor-targeting therapy. As an important perspective on carrier systems based on polymeric micelles, their feasibility as non-viral gene vectors is also summarized in this review article.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251249     DOI: 10.1016/s0169-409x(00)00124-1

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  362 in total

1.  Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery.

Authors:  Adem Guven; Irene A Rusakova; Michael T Lewis; Lon J Wilson
Journal:  Biomaterials       Date:  2011-11-12       Impact factor: 12.479

Review 2.  Molecular-targeted nanotherapies in cancer: enabling treatment specificity.

Authors:  Elvin Blanco; Angela Hsiao; Guillermo U Ruiz-Esparza; Matthew G Landry; Funda Meric-Bernstam; Mauro Ferrari
Journal:  Mol Oncol       Date:  2011-10-25       Impact factor: 6.603

Review 3.  Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

Authors:  Rolando E Yanes; Fuyuhiko Tamanoi
Journal:  Ther Deliv       Date:  2012-03

4.  3-Helix micelles stabilized by polymer springs.

Authors:  He Dong; Jessica Y Shu; Nikhil Dube; Yufei Ma; Matthew V Tirrell; Kenneth H Downing; Ting Xu
Journal:  J Am Chem Soc       Date:  2012-07-09       Impact factor: 15.419

5.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

6.  Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs.

Authors:  Robert Luxenhofer; Anita Schulz; Caroline Roques; Shu Li; Tatiana K Bronich; Elena V Batrakova; Rainer Jordan; Alexander V Kabanov
Journal:  Biomaterials       Date:  2010-03-26       Impact factor: 12.479

Review 7.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

Review 8.  Hybrid nanoparticles for combination therapy of cancer.

Authors:  Chunbai He; Jianqin Lu; Wenbin Lin
Journal:  J Control Release       Date:  2015-09-24       Impact factor: 9.776

9.  A biodegradable pH-sensitive micelle system for targeting acidic solid tumors.

Authors:  Vijay A Sethuraman; Myung Cheon Lee; You Han Bae
Journal:  Pharm Res       Date:  2007-11-13       Impact factor: 4.200

10.  Solid-state structure of polypeptide-based rod-coil block copolymers: folding of helices.

Authors:  M Łosik; S Kubowicz; B Smarsly; H Schlaad
Journal:  Eur Phys J E Soft Matter       Date:  2004-11-29       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.